AUTOIMMUNE THROMBOCYTOPENIA
Clinical trials for AUTOIMMUNE THROMBOCYTOPENIA explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE THROMBOCYTOPENIA trials appear
Sign up with your email to follow new studies for AUTOIMMUNE THROMBOCYTOPENIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug IASO-782 aims to tame immune attacks on blood cells
Disease control Recruiting nowThis early-stage trial is testing a new drug called IASO-782 in 16 adults with autoimmune thrombocytopenia (ITP) or warm autoimmune hemolytic anemia (wAIHA). These conditions cause the immune system to mistakenly attack blood cells. The study's main goal is to check the drug's sa…
Matched conditions: AUTOIMMUNE THROMBOCYTOPENIA
Phase: PHASE1 • Sponsor: Shanghai IASO Biotechnology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New study aims to crack the code of autoimmune diseases
Knowledge-focused Recruiting nowThis study is collecting blood, urine, and stool samples from 500 children with autoimmune diseases and healthy controls. Researchers will analyze these samples to find molecular patterns that could help diagnose these conditions and guide treatment decisions. The goal is to crea…
Matched conditions: AUTOIMMUNE THROMBOCYTOPENIA
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:28 UTC